Model of Angiogenesis in Mice with Severe Combined Immunodeficiency (SCID) and Xenoengrafted with Epstein-Barr Virus-Transformed B Cells

Comparative Medicine

Volumn 54, Issue 2, 2004, Pages 209-215

  Woodford, Nina L ^a   Call, Douglas R ^b   Remick, Daniel G ^b   Rochford, Rosemary ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; ENDOTHELIUM CELL; EPSTEIN BARR VIRUS; FEMALE; IMMUNOHISTOCHEMISTRY; LYMPHOBLASTOID CELL; MICROVASCULATURE; MOUSE; NONHUMAN; SCID MOUSE; XENOGRAFT;

ANIMALS; ANTIGENS, CD31; B-LYMPHOCYTES; CELL LINE; CELL TRANSPLANTATION; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; INTERLEUKIN-8; LYMPHOMA; MICE; MICE, SCID; MICROCIRCULATION; NEOVASCULARIZATION, PHYSIOLOGIC; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 2342578167     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Arenberg, D. A., S. L. Kunkel, P. J. Polverini, M. Glass, M. D. Burdick, and R. M. Strieter. 1996. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J. Clin. Invest. 97:2792-2802.
2. Baluk, P., S. Morikawa, A. Haskell, M. Mancuso, and D. M. McDonald. 2003. Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am. J. Pathol. 163:1801-1815.
3. Buchler, P., H. A. Reber, A. Ullrich, M. Shiroiki, M. Roth, M. W. Buchler, R. S. Lavey, H. Friess, and O. J. Hines. 2003. Pancreatic cancer growth is inhibited by blockade of VEGF-RII. Surgery 134:772-782.
4. Cen, H. and J. McKnight. 1994. EBV-immortalized isogenic human B-cell clones exhibit differences in DNA-protein complex formation on the BZLF1 and BRLF1 promoter regions among latent, lytic and TPA-activated cell lines. Virus Res. 31:89-107.
5. Chomczynski, P. and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thyocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
6. Crawford, D. H. 2001. Biology and disease associations of Epstein-Barr virus. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356:461-473.
7. DeForge, L. E. and D. G. Remick. 1991. Sandwich ELISA for detection of picogram quantities of interleukin-8. Immunol. Invest. 20:89-97.
8. di Celle, P. F., A. Carbone, D. Marchis, D. Zhou, S. Sozzani, S. Zupo, M. Pini, A. Mantovani, and R. Foa. 1994. Cytokine gene expression in B-cell chronic lymphocytic leukemia: evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein. Blood 84:220-228.
9. Dorshkind, K., S. B. Pollack, M. J. Bosma, and R. A. Phillips. 1985. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (SCID). J. Immunol. 134:3798-3801.
10. Eliopoulos, A. G., N. J. Gallagher, S. M. Blake, C. W. Dawson, and L. S. Young. 1999. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J. Biol. Chem. 274:16085-16096.
11. Fuzzati-Armentero, M. T., and M. A. Duchosal. 1998. hu-PBL-SCID mice: an in vivo model of Epstein-Barr virus-dependent lymphoproliferative disease. Histol. Histopathol. 13:155-168.
12. Hashizume, H., P. Baluk, S. Morikawa, J. W. McLean, G. Thurston, S. Roberge, R. K. Jain, and D. M. McDonald. 2000. Openings between defective endothelial cells explain tumor vessel leakiness. Am. J. Pathol. 156:1363-1380.
13. + T cells from young and old mice. J. Immunol. 150:3602-3614.
14. Johannessen, I. and D. H. Crawford. 1999. In vivo models for Epstein-Barr virus (EBV)-associated B cell lymphoproliferative disease (BLPD). Rev Med Virol 9:263-277.
15. Kieff, E. 1996. Epstein-Barr virus and its replication. In K. D. Fields, P. M. Howley, R. M. Chanock, J. L. Molnick, T. P. Monath, B. Roizman, and S. E. Strauss (ed.), Fields virology. Lippincott-Raven, Philadelphia.
16. Kitadai, Y., K. Haruma, K. Sumii, S. Yamamoto, T. Ue, H. Yokozaki, W. Yasui, Y. Ohmoto, G. Kajiyama, I. J. Fidler, and E. Tahara. 1998. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am. J. Pathol. 152:93-100.
17. Klein, S. C., D. Kube, H. Abts, V. Diehl, and H. Tesch. 1996. Promotion of IL8, IL10, TNF alpha and TNF beta production by EBV infection. Leuk. Res. 20:633-636.
18. Koch, A. E., P. J. Polverini, S. L. Kunkel, L. A. Harlow, L. A. DiPietro, V. M. Elner, S. G. Elner, and R. M. Strieter. 1992. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258:1798-1801.
19. Levine, A. M. 1992. Acquired immunodeficiency syndrome-related lymphoma. Blood 80:8-20.
20. Masucci, M. G., M. T. Bejarano, G. Masucci, and E. Klein. 1983. Large granular lymphocytes inhibit the in vitro growth of autologous Epstein-Barr virus-infected B cells. Cell. Immunol. 76:311-321.
21. McCormick, K. H., B. C. Giovanella, G. Klein, K. Nilsson, and J. S. Stehlin. 1981. Diploid human lymphoblastoid and Burkitt lymphoma cell lines: susceptibility to murine NK cells and heterotransplantation to nude mice. Int. J. Cancer 28:455-458.
22. Moore, B. B., D. A. Arenberg, K. Stoy, T. Morgan, C. L. Addison, S. B. Morris, M. Glass, C. Wilke, Y. Y. Xue, S. Sitterding, S. L. Kunkel, M. D. Burdick, and R. M. Strieter. 1999. Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. Am. J. Pathol. 154:1503-1512.
23. Moore, B. B., M. P. Keane, C. L. Addison, D. A. Arenberg, and R. M. Strieter. 1998. CXC chemokine modulation of angiogenesis: the importance of balance between angiogenic and angiostatic members of the family. J. Invest. Med. 46:113-120.
24. Morohashi, H., T. Miyawaki, H. Nomura, K. Kuno, S. Murakami, K. Matsushima, and N. Mukaida. 1995. Expression of both types of human interleukin-8 receptors on mature neutrophils, monocytes, and natural killer cells. J. Leukoc. Biol. 57:180-187.
25. Mosier, D. E., S. M. Baird, M. B. Kirven, R. J. Gulizia, D. B. Wilson, R. Kubayashi, G. Picchio, J. L. Garnier, J. L. Sullivan, and T. J. Kipps. 1990. EBV-associated B cell lymphomas following transfer of human peripheral blood lymphocytes to mice with severe combined immune deficiency, p. 317-323. In M. Potter, and F. Melchers (ed.), Current topics in microbiology and immunology: mechanisms in B-cell neoplasia. Springer-Verlag, Berlin-Heidelberg.
26. Murono, S., H. Inoue, T. Tanabe, I. Joab, T. Yoshizaki, M. Furukawa, and J. S. Pagano. 2001. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc. Natl. Acad. Sci. U S A 98:6905-6910.
27. Murphy, W. J., V. Kumar, and M. Bennett. 1987. Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized. J. Exp. Med. 166:1499-509.
28. Okunieff, P., B. M. Fenton, L. Zhang, F. G. Kern, T. Wu, J. R. Greg, and I. Ding. 2003. Fibroblast growth factors (FGFS) increase breast tumor growth rate, metastases, blood flow, and oxygenation without significant change in vascular density. Adv. Exp. Med. Biol. 530:593-601.
29. Pepper, M. S., S. J. Mandriota, J. D. Vassalli, L. Orci, and R. Montesano. 1996. Angiogenesis-regulating cytokines: activities and interactions. Curr. Topics Microbiol. Immunol. 213:31-67.
30. Picchio, G. R., R. Kobayashi, M. Kirven, S. M. Baird, T. J. Kipps, and D. E. Mosier. 1992. Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in hu-PBL-SCID mice. Cancer Res. 52:2468-2477.
31. Presta, M., M. Belleri, A. Vecchi, J. Hesselgesser, A. Mantovani, and R. Horuk. 1998. Noncompetitive, chemokine-mediated inhibition of basic fibroblast growth factor-induced endothelial cell proliferation. J. Biol. Chem. 273:7911-7919.
32. Randhawa, P. S., S. A. Yousem, I. L. Paradis, J. A. Dauber, B. P. Griffith, and J. Locker. 1989. The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients. Am. J. Clin. Pathol. 92:177-185.
33. Rochford, R., M. J. Cannon, R. E. Sabbe, K. Adusumilli, G. Picchio, J. M. Glynn, D. J. Noonan, D. E. Mosier, and M. V. Hobbs. 1997. Common and idiosyncratic patterns of cytokine gene expression by Epstein-Barr virus transformed human B cell lines. Viral Immunol. 10:183-195.
34. Rochford, R., M. V. Hobbs, J.-L. Garnier, N. R. Cooper, and M. J. Cannon. 1993. Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes. Proc. Natl. Acad. Sci. USA 90:352-356.
35. Rochford, R. and D. E. Mosier. 1995. Differential Epstein-Barr virus gene expression in B-cell subsets recovered from lymphomas in SCID mice after transplantation of human peripheral blood lymphocytes. J. Virol. 69:150-155.
36. Rochford, R. and D. E. Mosier. 1994. Immunobiology of Epstein-Barr virus-associated lymphomas. Clin. Immunol. Immunopathol. 71:256-259.
37. Rowe, M., L. S. Young, H. Crocker, S. Stokes, S. Henderson, and A. B. Rickinson. 1991. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: Implications for the pathogenesis of EBV-positive lymphomas in man. J. Exp. Med. 173:147-158.
38. Sebok, K., D. Woodside, A. al-Aoukaty, A. D. Ho, S. Gluck, and A. A. Maghazachi. 1993. IL-8 induces the locomotion of human IL-2-activated natural killer cells. Involvement of a guanine nucleotide binding (Go) protein. J. Immunol. 150:1524-1534.
39. Singh, R. K., M. Gutman, R. Radinsky, C. D. Bucana, and I. J. Fidler. 1994. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res. 54:3242-3247.
40. Smith, D. R., P. J. Polverini, S. L. Kunkel, M. B. Orringer, R. I. Whyte, M. D. Burdick, C. A. Wilke, and R. M. Strieter. 1994. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J. Exp. Med. 179:1409-1415.
41. Srivastava, M. D., R. Srivastava, and B. I. Srivastava. 1993. Constitutive production of interleukin-8 (IL-8) by normal and malignant human B-cells and other cell types. Leuk. Res. 17:1063-1069.
42. Strieter, R. M., C. L. Addison, J. E. Ehlert, M. P. Keane, J. A. Belperio, M. D. Burdick, and D. A. Arenberg. 1999. Use of immunodeficient mice for the evaluation of CXC chemokines in the regulation of tumor-associated angiogenesis. Ilar J. 40:175-182.
43. Strieter, R. M., P. J. Polverini, D. A. Arenberg, A. Walz, G. Opdenakker, J. Van Damme, and S. L. Kunkel. 1995. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J. Leukoc. Biol. 57:752-762.
44. Tanner, J. and G. Tosato. 1991. Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice. J. Clin. Invest. 88:239-247.
45. Vacca, A., D. Ribatti, M. Fanelli, F. Costantino, B. Nico, R. Di Stefano, G. Serio, and F. Dammacco. 1996. Expression of tenascin is related to histologic malignancy and angiogenesis in b-cell non-Hodgkin's lymphomas. Leuk. Lymphoma 22:473-481.
46. Vacca, A., D. Ribatti, M. Iurlaro, A. Albini, M. Minischetti, F. Bussolino, A. Pellegrino, R. Ria, M. Rusnati, M. Presta, V. Vincenti, M. G. Persico, and F. Dammacco. 1998. Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis. Int. J. Clin. Lab. Res. 28:55-68.
47. Virag, J. I. and C. E. Murry. 2003. Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. Am. J. Pathol. 163:2433-2440.
48. Weidner, N. 1995. Intratumor microvessel density as a prognostic factor in cancer. Am. J. Pathol. 147:9-19.
49. Weidner, N., J. P. Semple, W. R. Welch, and J. Folkman. 1991. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med. 324:1-8.
50. Yoneda, J., H. Kuniyasu, M. A. Crispens, J. E. Price, C. D. Bucana, and I. J. Fidler. 1998. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. J. Natl. Cancer Inst. 90:447-454.
51. Yoshida, S., H. Amano, I. Hayashi, H. Kitasato, M. Kamata, M. Inukai, H. Yoshimura, and M. Majima. 2003. COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivo. Lab. Invest. 83:1385-1394.
52. Yoshizaki, T., T. Horikawa, R. Qing-Chun, N. Wakisaka, H. Takeshita, T. S. Sheen, S. Y. Lee, H. Sato, and M. Furukawa. 2001. Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma. Clin. Cancer Res. 7:1946-1951.